163 filings
Page 5 of 9
6-K
awqvwil0
7 Sep 22
Report of Foreign Private Issuer
9:29am
EFFECT
c3czbd
19 Aug 22
Notice of effectiveness
12:15am
CORRESP
x6ra211q
17 Aug 22
Correspondence with SEC
12:00am
UPLOAD
ddbv7i gqzorzvjd
16 Aug 22
Letter from SEC
12:00am
6-K
dy5w0c m4mgs4ezu5
11 Aug 22
Inspira™ Technologies Reports Second Quarter 2022 Financial Results
10:07am
F-3
9a8ls098s2mxjffu90
10 Aug 22
Shelf registration (foreign)
5:13pm
6-K
od2fxnr
10 Aug 22
Report of Foreign Private Issuer
4:01pm
6-K
9x54m7e 7s50l4i
8 Aug 22
Copyright © 2018 - 2022 Inspira Technologies OXY B.H.N. LTD., All rights reserved August 2022 Investor Presentation
9:17am
6-K
ktq0b297x yg3chq5ix
11 Jul 22
Report of Foreign Private Issuer
9:29am
6-K
2e7rol
7 Jul 22
The agreement signed with Glo-Med Networks for the potential deployment of HYLA™ Blood Sensors over a 3-year period, subject to regulatory approvals
9:16am
6-K
rl9xlsxhesmc2t4
6 Jul 22
HYLA™ blood sensor intends to reduce the need for actual blood samples to be taken from patients
9:07am
6-K
u8mad
19 May 22
Inspira™ Technologies Announces First Quarter 2022 Financial Results
9:05am
EFFECT
65hsm s5oo7
20 Apr 22
Notice of effectiveness
12:15am
POS AM
t7dm3j5to ateqn
14 Apr 22
Prospectus update (post-effective amendment)
4:40pm
6-K
cx8xtfl
6 Apr 22
Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M
9:25am
20-F
j24y 9ajm4b
31 Mar 22
Annual report (foreign)
4:48pm
6-K
guazes3d
31 Mar 22
Inspira Technologies Releases Q4 & FY2021 Financial Results
4:08pm
6-K
d76hqfp4 ka
3 Feb 22
Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO) - Daniella Yeheskely-Hayon PhD
9:06am
6-K
9iflhpcvu5da vvw8
1 Feb 22
Report of Foreign Private Issuer
8:58am
6-K
feaz5zwa1uck4fqobqkh
31 Jan 22
Inspira Technologies Signs a Strategic Agreement in the U.S. to
9:06am